Vitamin D deficiency is related to thyroid antibodies in autoimmune thyroiditis

Central European Journal of Immunology

Volumn 39, Issue 4, 2014, Pages 493-497

  Unal, Asli Dogruk ^a   Tarcin, Ozlem ^a   Parildar, Hulya ^a   Cigerli, Ozlem ^a   Eroglu, Hacer ^a   Demirag, Nilgun Guvener ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Autoimmunity; Thyroid; Vitamin D

Indexed keywords

ANTITHYROID AGENT; CALCIUM; PARATHYROID HORMONE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; VITAMIN D;

ADULT; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PREVALENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84919442872     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2014.47735     Document Type: Article

References (36)

1. Arnson Y, Amital H, Shoenfeld Y (2007): Vitamin D and au-toimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66: 1137-1142.
2. Baeke F, Takiishi T, Korf H., et al. (2010): Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10: 482-496.
3. Deluca HF, Cantorna MT (2001): Vitamin D: its role and uses in immunology. FASEB J 15: 2579-2585.
4. Cantorna MT, Mahon BD (2004): Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 229: 1136-1142.
5. Tang J, Zhou R, Luger D., et al. (2009): Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182: 4624-4632.
6. Cutolo M, Otsa K, Uprus M., et al. (2007): Vitamin D in rheumatoid arthritis. Autoimmun Rev 7: 59-64.
7. Doria A, Arienti S, Rampudda M., et al. (2008): Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 7: 192-197.
8. Kamen DL, Cooper GS, Bouali H, et al. (2006): Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5: 114-117.
9. Tamer G, Arik S, Tamer I., Coksert D (2011): Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 21: 891-896.
10. Bozkurt NC, Karbek B, Ucan B., et al. (2013): The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract 19: 479-484.
11. Cantorna MT, Zhu Y, Froicu M., Wittke A (2004): Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80: 1717S-1720S.
12. Li HS, Verginis P, Carayanniotis G (2006): Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis. Clin Exp Immunol 144: 467-474.
13. Antico A, Tampoia M, Tozzoli R., Bizzaro N (2012): Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12: 127-136.
14. Ikeda U, Wakita D, Ohkuri T., et al. (2010): 1alpha, 25-Dihy-droxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 134: 7-16.
15. Taher YA, van Esch BC, Hofman GA, et al. (2008): 1al-pha, 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 180: 5211-5221.
16. Hewison M, Freeman L, Hughes S.V., et al. (2003): Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170: 5382-5390.
17. Piemonti L, Monti P, Sironi M., et al. (2000): Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443-4451.
18. Széles L, Keresztes G, Töröcsik D, et al. (2009): 1,25-dihy-droxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell pheno-type. J Immunol 182: 2074-2083.
19. Correale J, Ysrraelit MC, Gaitán MI (2011): Vitamin D-mediated immune regulation in multiple sclerosis. J Neurol Sci 311: 23-31.
20. Kivity S, Agmon-Levin N, Zisappl M., et al. (2011): Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 8: 243-247.
21. Cigerli O, Parildar H, Unal A.D., et al. (2013): Vitamin D deficiency is a problem for adult out-patients? A university hospital sample in Istanbul, Turkey. Public Health Nutr 16: 1306-1313.
22. Erkal MZ, Wilde J, Bilgin Y., et al. (2006): High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17: 1133-1140.
23. Ralston SH, Binkley N, Boonen S., et al. (2011): Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency. Calcif Tissue Int 88: 485-494.
24. Fournier C, Gepner P, Sadouk M., Charreire J (1990): In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 54: 53-63.
25. Misharin A, Hewison M, Chen C.R., et al. (2009): Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology 150: 1051-1060.
26. Kozai M, Yamamoto H, Ishiguro M., et al. (2013): Thyroid hormones decrease plasma 1alpha, 25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hy-droxyvitamin D3 1alpha-hydroxylase gene (CYP27B1). Endocrinology 154: 609-622.
27. Pantazi H, Papapetrou PD (2000): Changes in parameters of bone and mineral metabolism during therapy for hyperthy-roidism. J Clin Endocrinol Metab 85: 1099-1106.
28. Hollowell JG, Staehling NW, Flanders W.D., et al. (2002): Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499.
29. Ng HP, Banga JP, Kung AW (2004): Development of a mu-rine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase. Endocrinology 145: 809-816.
30. McLachlan SM, Nagayama Y, Rapoport B (2005): Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26: 800-832.
31. Many MC, Maniratunga S, Varis I., et al. (1995): Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147: 311-320.
32. Caturegli P, Hejazi M, Suzuki K., et al. (2000): Hypothyroid-ism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A 97: 1719-1724.
33. Kimura H, Kimura M, Tzou S.C., et al. (2005): Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization. Endocrinology 146: 1154-1162.
34. Nagayama Y (2005): Animal models of Graves' hyperthy-roidism. Endocr J 52: 385-394.
35. Yasuda T, Okamoto Y, Hamada N., et al. (2012): Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine 42: 739-741.
36. Yasuda T, Okamoto Y, Hamada N., et al. (2013): Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine 43: 230-232.